A Systematic Review of Minimally Invasive Approaches to Uterine Fibroid Treatment for Improving Quality of Life and Fibroid-Associated Symptoms

[1]  J. Segars,et al.  A systematic review of the psychosocial impact of fibroids before and after treatment. , 2020, American journal of obstetrics and gynecology.

[2]  S. Ferrero,et al.  A Prospective Intervention Trial on Tailored Radiofrequency Ablation of Uterine Myomas , 2020, Medicina.

[3]  L. Waetjen,et al.  Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas: Clinical Outcomes during Early Adoption into Surgical Practice. , 2020, Journal of minimally invasive gynecology.

[4]  Jae-Seong Lee,et al.  Safety and Efficacy of Ultrasound-Guided High-Intensity Focused Ultrasound Treatment for Uterine Fibroids and Adenomyosis. , 2019, Ultrasound in medicine & biology.

[5]  Michael J. Miller,et al.  FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery , 2019, American journal of obstetrics and gynecology.

[6]  G. Mauri,et al.  Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study , 2018, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[7]  Chun-hong Hu,et al.  Diagnosis and treatment of submucous myoma of the uterus with interventional ultrasound , 2018, Oncology letters.

[8]  P. McCulloch,et al.  Evaluation of high‐intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study , 2018, BJOG : an international journal of obstetrics and gynaecology.

[9]  Lian Zhang,et al.  A retrospective study of ultrasound-guided high intensity focussed ultrasound ablation for multiple uterine fibroids in South Africa , 2018, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[10]  Shijin Wang,et al.  Pilot study: safety and effectiveness of simple ultrasound-guided high-intensity focused ultrasound ablating uterine leiomyoma with a diameter greater than 10 cm. , 2017, The British journal of radiology.

[11]  I. Kirsch Response Expectancy and the Placebo Effect. , 2018, International review of neurobiology.

[12]  Xiaoying Wang,et al.  The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China , 2016, Journal of therapeutic ultrasound.

[13]  Haiyang Li,et al.  Effectiveness of Ultrasound-guided Percutaneous Microwave Ablation for Symptomatic Uterine Fibroids: A Multicenter Study in China , 2016 .

[14]  B. Gao,et al.  Uterine Leiomyomas: Safety and Efficacy of US-guided Suprapubic Transvaginal Radiofrequency Ablation at 1-year Follow-up. , 2016, Radiology.

[15]  E. Vittinghoff,et al.  PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. , 2016, Fertility and sterility.

[16]  J. Reekers,et al.  Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. , 2007, American journal of obstetrics and gynecology.

[17]  Wen-zhi Chen,et al.  Feasibility, Safety, and Efficacy of Accurate Uterine Fibroid Ablation Using Magnetic Resonance Imaging–Guided High‐Intensity Focused Ultrasound With Shot Sonication , 2015, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[18]  H. Brölmann,et al.  The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids , 2015, Gynecological Surgery.

[19]  F. Taran,et al.  Radiofrequency Volumetric Thermal Ablation of Fibroids and Laparoscopic Myomectomy: Long-Term Follow-up From a Randomized Trial. , 2015, Geburtshilfe und Frauenheilkunde.

[20]  P. Liang,et al.  A retrospective comparison of microwave ablation and high intensity focused ultrasound for treating symptomatic uterine fibroids. , 2015, European journal of radiology.

[21]  H. Brölmann,et al.  Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study , 2014, Gynecological Surgery.

[22]  N. Han,et al.  Magnetic resonance-guided focused ultrasound surgery (MRgFUS) of uterine fibroids in Singapore. , 2014, Annals of the Academy of Medicine, Singapore.

[23]  F. Whaley,et al.  Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas. , 2014, Journal of minimally invasive gynecology.

[24]  H. Verkooijen,et al.  Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates , 2014, European Radiology.

[25]  G. Collins,et al.  Use of placebo controls in the evaluation of surgery: systematic review , 2014, BMJ : British Medical Journal.

[26]  Liangdan Tang,et al.  Ultrasound-guided high-intensity focused ultrasound vs laparoscopic myomectomy for symptomatic uterine myomas. , 2014, Journal of minimally invasive gynecology.

[27]  Min Jung Park,et al.  Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. , 2014, Journal of vascular and interventional radiology : JVIR.

[28]  F. Fennessy,et al.  MR-guided focused ultrasound (MRgFUS) is effective for the distinct pattern of uterine fibroids seen in African-American women: data from phase III/IV, non-randomized, multicenter clinical trials , 2013, Journal of therapeutic ultrasound.

[29]  T. Kroencke,et al.  Clinical long-term outcome after uterine artery embolization: sustained symptom control and improvement of quality of life. , 2013, Journal of vascular and interventional radiology : JVIR.

[30]  Nathalie Gamache,et al.  Outpatient uterine artery embolization for symptomatic fibroids: short- and long-term single institution-based outcomes. , 2013, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[31]  J. G. Garza Leal,et al.  Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System. , 2011, Journal of minimally invasive gynecology.

[32]  J. Reekers,et al.  Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. , 2010, American journal of obstetrics and gynecology.

[33]  W. Lijuan,et al.  Effect of selective uterine artery embolization on symptomatic uterine fibroids , 2009 .

[34]  R. Bucek,et al.  Long-term quality of life assessment among patients undergoing uterine fibroid embolization. , 2009, AJR. American journal of roentgenology.

[35]  L. Murray,et al.  Uterine-artery embolization versus surgery for symptomatic uterine fibroids. , 2007, The New England journal of medicine.

[36]  J. Hindley,et al.  Gonadotrophin-Releasing Hormone and Magnetic-Resonance–Guided Ultrasound Surgery for Uterine Leiomyomata , 2006, Obstetrics and gynecology.

[37]  J. Spies,et al.  Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. , 2004, American journal of obstetrics and gynecology.

[38]  D. van Rensburg,et al.  Uterine artery embolization for symptomatic fibroids , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[39]  David B Dunson,et al.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. , 2003, American journal of obstetrics and gynecology.

[40]  K. Coyne,et al.  The UFS‐QOL, a New Disease‐Specific Symptom and Health‐Related Quality of Life Questionnaire for Leiomyomata , 2002, Obstetrics and gynecology.